Dr Donal McLornan


  • Fee assured

This healthcare professional let us know that they are currently:

  • Accepting new patients
  • Available for:
    • Face-to-face consultations
    • Phone consultations
    • Video consultations

Last updated: 29 Jun 2020

Specialises in

  • General
  • Haemato-oncology

About me

Dr. Donal McLornan graduated in 1999 from Queen’s University belfast with Honours. Postgraduate training was completed in Belfast with a further one year period spent in Hammersmith Hospital specialising in Allogeneic and Autologous Stem Cell Transplantation. During his post-graduate training he was awarded a prestigious MRC fellowship and completed a PhD investigating drug resistance in Acute Myeloid Leukaemia for which he received several awards. Clinically he specialises in Haemato-oncology and Stem Cell Transplantation. He has a particular interest in Myeloproliferative Disorders, Myelodysplasia, Acute Myeloid Leukaemia and Allogeneic Stem Cell Transplantation. He sits on the NCRN MPN working group and is the chair of the MPN subcommittee of the Chronic Malignancy Working Party of EBMT and is the lead for the Myeloid Disorders MDM across South East London. He has authored over 50 papers and has a special reserach interest in Myeloproliferative Disease. He is a member of EHA, EBMT and BSH. He regularly speaks internationally on MPN, MDS and allogeneic SCT.

Areas of interest

Haemato-oncology; Acute Leukaemia; Myeloproliferative Neoplasms; Myelodysplastic Syndromes; Stem Cell Transplantation; General Haematology; Immuno-Haematology

Medical secretaries

My qualifications & training
Consultant's practices
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.